💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Myriad Genetics, Inc. (MYGN)
« Back to company indexMYGN Chatter Timeline
Stock Ticker for MYGN
Most Active Tweeters for MYGN
| User | Tweets |
|---|---|
| @Tickeron | 7 |
| @FlashAlert_me | 3 |
| @stockmktgenius | 2 |
| @Allstocknews | 2 |
| @NguyenDuyAnh933 | 1 |
Recent Tweets for MYGN
 |
@Tickeron $MYGN's price moved below its 50-day Moving Average on April 7, 2021. View odds for this and other indicators:… https://t.co/XqUnrecsB0 April 19th 2021, 5:04am |
 |
@newsfilterio Dennis H. Langer, M.D., J.D. to Join the Board of Directors of Brooklyn ImmunoTherapeutics $BTX $MYGN https://t.co/CyhJwecLqx April 17th 2021, 12:04am |
 |
@NguyenDuyAnh933 RT @markminervini: Some of you have asked me to post some trades that stopped me out. $MYGN was bought on 4/6 and immediately knocked me ou… April 16th 2021, 9:04pm |
 |
@markminervini Some of you have asked me to post some trades that stopped me out. $MYGN was bought on 4/6 and immediately knocked… https://t.co/qpdH5Z86QX April 16th 2021, 1:04pm |
|
@Tickeron $MYGN's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds f… https://t.co/Vyrd3jf8Km April 16th 2021, 12:04am |
 |
@Allstocknews $MYGN New Form DEFA14A for Myriad Genetics, Inc. From our Stock News Alerts App April 15th 2021, 12:04pm |
|
@Allstocknews $MYGN New Form DEF 14A for Myriad Genetics, Inc. From our Stock News Alerts App April 15th 2021, 11:04am |
 |
@fintel_io $MYGN / Myriad Genetics files form DEF 14A https://t.co/10uBQNeH4w April 15th 2021, 11:04am |
 |
@FlashAlert_me $MYGN [15s. delayed] filed form DEF 14A on April 15, 07:05:26 https://t.co/16Zv0iXODQ April 15th 2021, 11:04am |
|
@FlashAlert_me $MYGN [15s. delayed] filed form DEFA14A on April 15, 07:05:59 https://t.co/qPXyW7gOWX April 15th 2021, 11:04am |
 |
@InsiderAlerts4U $MYGN: New Insider Filing on MYRIAD GENETICS INC's Former E.V.P., General Counsel BENJAMIN JACKSON: https://t.co/XmS7afHuly April 15th 2021, 1:04am |
 |
@StockTexts $MYGN Myriad Genetics, Inc. SEC Filing: Form 4 https://t.co/U2imaWPAaf April 15th 2021, 12:04am |
|
@FlashAlert_me $MYGN [15s. delayed] filed SEC form 4: Former E.V.P., General Counsel Jackson Benjamin: https://t.co/5x4KDkxqSS April 14th 2021, 11:04pm |
|
@Tickeron $MYGN in Downtrend: Stochastic indicator sits in oversold zone for 3 days. View odds for this and other indicators:… https://t.co/v1gW3jmaJ7 April 14th 2021, 4:04pm |
|
@Tickeron $MYGN enters a Downtrend because Momentum Indicator dropped below the 0 level on April 9, 2021. View odds for this… https://t.co/kHl5g5Wqx5 April 12th 2021, 11:04pm |
|
@Tickeron $MYGN in Downtrend: Stochastic indicator reaching into oversold zone View odds for this and other indicators:… https://t.co/oZCSqjC9fl April 10th 2021, 5:04am |
|
@Tickeron $MYGN in Downtrend: Stochastic indicator recovers from overbought zone. View odds for this and other indicators:… https://t.co/bMACKHw0px April 9th 2021, 4:04pm |
 |
@TrabeHawk RT @TradeHawk: $MYGN Myriad Genetics gets Aetna insurance coverage for its BRACAnalysis CDx diagnostic now calling it medically necessary.… April 9th 2021, 4:04pm |
 |
@TerraPharma1 @bio_report Lol. What's $MYGN's excuse today? April 7th 2021, 7:04pm |
 |
@MichalFutera RT @Tickeron: $MYGN's price moved above its 50-day Moving Average on March 31, 2021. View odds for this and other indicators: https://t.co/… April 7th 2021, 8:04am |
|
@Tickeron $MYGN's price moved above its 50-day Moving Average on March 31, 2021. View odds for this and other indicators:… https://t.co/PjRdwCWxHT April 7th 2021, 8:04am |
 |
@stockmktgenius $MYGN Myriad Genetics, Inc. - C Top stock up 196% from low. Close: 30.50 VolvsAvg: 2.42 Liq: $65M https://t.co/3PaXRdedRG April 7th 2021, 1:04am |
 |
@AlertTrade MOST ACTIVE: $MYGN Myriad Genetics, Inc https://t.co/jJEfBqW6Fd ? TradeIdeas via ? https://t.co/VS8RO1bzXJ April 6th 2021, 2:04pm |
 |
@dixielee1969 $MYGN breaks out, nearly hits 34 April 6th 2021, 2:04pm |
|
@stockmktgenius $MYGN Myriad Genetics, Inc. - C Top stock up 196% from low. Close: 31.32 VolvsAvg: 0.61 Liq: $13M https://t.co/3PaXRdedRG April 6th 2021, 1:04am |
|
@Tickeron $MYGN's price moved above its 50-day Moving Average on March 31, 2021. View odds for this and other indicators:… https://t.co/i6Z4BaATHC April 5th 2021, 1:04am |
|
@Tickeron $MYGN's price moved above its 50-day Moving Average on March 31, 2021. View odds for this and other indicators:… https://t.co/0vF78bf5pq April 3rd 2021, 6:04am |
|
@stockmktgenius $MYGN Myriad Genetics, Inc. - C Top stock up 196% from low. Close: 31.21 VolvsAvg: 1.23 Liq: $30M https://t.co/3PaXRdedRG April 3rd 2021, 1:04am |
|
@InsiderAlerts4U $MYGN: New Insider Filing on MYRIAD GENETICS INC's Chief Growth Officer ERIC SANTA: https://t.co/QhVKo8rh1B April 2nd 2021, 5:04pm |
 |
@SwingTradeBot Recent $MYGN technical alerts: Pocket Pivot plus 10 more alerts... https://t.co/1ayvR7H0Cj April 2nd 2021, 3:04pm |
|
@StockTexts $MYGN Myriad Genetics, Inc. SEC Filing: Form 4 https://t.co/YaoySRdAtw April 2nd 2021, 3:04pm |
|
@newsfilterio 16,420 shares acquired by Santa Eric (Chief Growth Officer), reported in a new form 4 filed with the SEC $MYGN https://t.co/eQkaJVQ709 April 2nd 2021, 3:04pm |
|
@FlashAlert_me $MYGN [15s. delayed] filed SEC form 4: Chief Growth Officer Santa Eric: Granted 16,420 of Common Stock at price $0… https://t.co/8lKxTKRbep April 2nd 2021, 3:04pm |
|
@newsfilterio Form 3 (initial statement of beneficial ownership of securities) filed with the SEC $MYGN https://t.co/NjWsDIJsSy April 2nd 2021, 3:04pm |
|
@FlashAlert_me $MYGN [15s. delayed] filed SEC form 3: Chief Growth Officer Santa Eric: https://t.co/oegG1woF8S April 2nd 2021, 3:04pm |
|
@stockmktgenius $MYGN Myriad Genetics, Inc. - C Top stock up 196% from low. Close: 31.21 VolvsAvg: 1.22 Liq: $29M https://t.co/3PaXRdedRG April 2nd 2021, 12:04am |
|
@Tickeron $MYGN's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds f… https://t.co/J51eMJ5GD1 April 1st 2021, 10:04am |
|
@stockmktgenius $MYGN Myriad Genetics, Inc. - C Top stock up 196% from low. Close: 30.45 VolvsAvg: 1.33 Liq: $29M https://t.co/3PaXRcWCt6 April 1st 2021, 12:04am |
 |
@SmallCapsDaily $MYGN Sera Prognostics Appoints Robert G. Harrison as Chief Information Officer GlobeNewswire… https://t.co/AVI0xYYxNG March 31st 2021, 4:03pm |
|
@FlashAlert_me $MYGN [15s. delayed]: Issued Press Release on March 31, 08:00:00: Sera Prognostics Appoints Robert G. Harrison as C… https://t.co/H3Pv3vmlyS March 31st 2021, 12:03pm |
 |
@formwhisperscom #FWSells $MYGN Hart Jayne B., Chief People Officer of MYRIAD GENETICS INC sold 58,000 shares on 2021-03-29. https://t.co/tmcbIRlUbk March 31st 2021, 3:03am |
 |
@mehabecapital Insider Activity seen in $MYGN, Hart Jayne B. (Chief People Of) Option Exercise, Total-Shares = 58,000, Transactio… https://t.co/l76CWcpY3c March 30th 2021, 10:03pm |
|
@InsiderAlerts4U $MYGN: New Insider Filing on MYRIAD GENETICS INC's Chief People Officer JAYNE B. HART: https://t.co/y24XVwqsJ2 March 30th 2021, 10:03pm |
 |
@insiderbuyings $MYGN new insider selling: 58000 shares. https://t.co/qVAU9HFooF March 30th 2021, 10:03pm |
|
@StockTexts $MYGN Myriad Genetics, Inc. SEC Filing: Form 4 https://t.co/HaYkzsBc3h March 30th 2021, 10:03pm |
|
@fintel_io Insider Hart Jayne B. reports selling 58,000 shares of $MYGN for a total cost of $1,740,000.00 https://t.co/iqbFtp60oK March 30th 2021, 10:03pm |
|
@MichalFutera RT @Tickeron: $MYGN's price moved above its 50-day Moving Average on March 25, 2021. View odds for this and other indicators: https://t.co/… March 30th 2021, 7:03am |
|
@Tickeron $MYGN's price moved above its 50-day Moving Average on March 25, 2021. View odds for this and other indicators:… https://t.co/baWnogAQsU March 30th 2021, 7:03am |
|
@newsfilterio Myriad Genetics names Eric Santa chief growth officer $MYGN https://t.co/2eZONczdnZ March 30th 2021, 1:03am |
 |
@trademarktrader HEALTH. ILLUMINATED. filed for trademark by Myriad Genetics, Inc. https://t.co/lSunuLqjPW #HEALTHILLUMINATED $MYGN… https://t.co/O0XHt7Iap0 March 29th 2021, 11:03pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
